Abstract
A relationship between endogenous endothelins and bladder overactivity has recently been suggested, but the related endothelin receptor subtype has not been identified. Here, to evaluate the involvement of endothelin-1 and its receptors in bladder overactivity, we investigated endothelin-1 levels and the expression of its receptors in the bladder of rats with bladder outlet obstruction (BOO), a model for bladder overactivity. We also investigated the effects of a selective endothelin ETA receptor antagonist, (E)-N-[6-methoxy-5-(2-methoxyphenoxy)[2,2′-bipyrimidin]-4-yl]-2-phenylethenesulfonamide monopotassium salt (YM598), on bladder functions in conscious BOO rats. Partial obstruction of the urethra led to a progressive increase in bladder weight from weeks 1 to 6. Binding assays performed using plasma membranes prepared from these bladders to estimate endothelin receptor density from the maximum [125I]endothelin-1 binding showed increased endothelin receptor density (about double) at 1, 2, and 6 weeks after the operation in the BOO bladder. The densities of endothelin ETA receptors in the bladder of sham-operated and BOO rats at 2 weeks after operation were about 3.5 and 5 times those of endothelin ETB receptors respectively. Furthermore, the endothelin-1 level was also increased in the BOO bladder. Two weeks after operation, BOO rats showed an increase in maximum bladder capacity and micturition volume and the generation of premicturition contractions. The frequency of premicturition contractions was dose-dependently reduced by YM598 (0.1–3 mg/kg, i.v.) without any effect on other voiding parameters in BOO rats. These data suggest that endothelin-1 and endothelin ETA receptors might be involved in the generation of premicturition contractions in BOO rats, and that endothelin ETA receptor antagonists such as YM598 may have ameliorating effects in patients with bladder overactivity associated with BOO.
Similar content being viewed by others
References
Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730–732
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem 72:248–254
Donoso MV, Salas C, Sepulveda G, Lewin J, Fournier A, Huidobro-Toro JP (1994) Involvement of ETA receptors in the facilitation by endothelin-1 of non-adrenergic non-cholinergic transmission in the rat urinary bladder. Br J Pharmacol 111:473–482
Garcia-Pascual A, Larsson B, Andersson K (1990) Contractile effects of endothelin-1 and localization of endothelin binding sites in rabbit lower urinary tract smooth muscle. Acta Physiol Scand 140:545–555
Greenland JE, Brading AF (1996) Urinary bladder blood flow changes during the micturition cycle in a conscious pig model. J Urol 156:1858–1861
Greenland JE, Brading AF (2001) The effect of bladder outflow obstruction on detrusor blood flow changes during the voiding cycle in conscious pigs. J Urol 165:245–248
Greenland JE, Hvistendahl JJ, Andersen H, Jorgensen TM, McMurray G, Cortina-Borja M, Brading AF, Frokiaer J (2000) The effect of bladder outlet obstruction on tissue oxygen tension and blood flow in the pig bladder. BJU Int 85:1109–1114
Guarneri L, Ibba M, Angelico P, Testa R (1991) Effects of oxybutynin, terodiline, and nifedipine on the cystometrogram in conscious rats with infravesical outflow obstruction. Pharmacol Res 24:263–272
Hoang D, Macarthur H, Gardner A, Westfall TC (2001) Endothelin-induced modulation of neuropeptide Y and norepinephrine release from the rat mesenteric bed. Am J Physiol Heart Circ Physiol 283:1523–1530
Igawa Y, Mattiasson A, Andersson KE (1994) Micturition and premicturition contractions in unanesthetized rats with bladder outlet obstruction. J Urol 151:244–249
Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86:2863–2867
Karim O, Van Koeveringe G, Mostwin J (1990) Development of abnormal voiding patterns following partial obstruction of the guinea pig urethra. J Urol 143:335A
Khan MA, Dashwood MR, Thompson CS, Mumtaz FH, Mikhailidis DP, Morgan RJ (1999) Up-regulation of endothelin-B (ETB) receptors and ETB receptor-mediated rabbit detrusor contraction in partial bladder outlet obstruction. BJU Int 84:714–719
Langenstroer P, Tang R, Divish B, Opgenorth T, Shapiro E, Lepor H (1997) Endothelins in canine genitourinary tissues. J Urol 157:1044–1048
Latifpour J, Fukumoto Y, Weiss RM (1995) Regional differences in the density and subtype specificity of endothelin receptors in rabbit urinary tract. Naunyn-Schmiedebergs Arch Pharmacol 352:459–468
Maggi CA, Giuliani S, Patacchini R, Santicioli P, Turini D, Barbanti G, Meli A (1989) Potent contractile activity of endothelin on the human isolated urinary bladder. Br J Pharmacol 96:755–757
Ogawa T, Kamo I, Pflug BR, Nelson JB, Seki S, Igawa Y, Nishizawa O, de Groat WC, Chancellor MB, Yoshimura N (2004) Differential roles of peripheral and spinal endothelin receptors in the micturition reflex in rats. J Urol 172:1533–1537
Okamoto-Koizumi T, Takeda M, Komeyama T, Hatano A, Tamaki M, Mizusawa T, Tsutsui T, Obara K, Tomita Y, Arai K, Takahashi K (1999) Pharmacological and molecular biological evidence for ETA endothelin receptor subtype mediating mechanical responses in the detrusor smooth muscle of the human urinary bladder. Clin Sci 96:397–402
Persson K, Garcia-Pascual A, Holmquist F, Andersson KE (1992) Endothelin-1-induced contractions of isolated pig detrusor and vesical arterial smooth muscle: calcium dependence and phosphoinositide hydrolysis. Gen Pharmacol 23:445–453
Saenz de Tejada I, Mueller JD, de Las Morenas A, Machado M, Moreland RB, Krane RJ, Wolfe HJ, Traish AM (1992) Endothelin in the urinary bladder. I. Synthesis of endothelin-1 by epithelia, muscle and fibroblasts suggests autocrine and paracrine cellular regulation. J Urol 148:1290–1298
Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto, Masaki T (1990) Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732–735
Schröder A, Chichester P, Kogan BA, Longhurst PA, Lieb J, Levin RM (2001) Effect of chronic bladder outlet obstruction on the blood flow of the rabbit urinary bladder. J Urol 165:640–646
Schröder A, Tajimi M, Matsumoto H, Schröder C, Brands M, Andersson KE (2004) Protective effect of an oral endothelin converting enzyme inhibitor on rat detrusor function after outlet obstruction. J Urol 172:1171–1174
Steers WD, de Groat WC (1988) Effect of bladder outlet obstruction on micturition reflex pathways in the rat. J Urol 140:864–871
Velasco C, Guarneri L, Leonardi A, Testa R (2003) Effects of intravenous and infravesical administration of suramin, terazosin and BMY 7378 on bladder instability in conscious rats with bladder outlet obstruction. BJU Int 92:131–136
Wada Y, Latifpour J, Sanematsu H, Afiatpour P, Wang Z, Saito M, Nishi K, Weiss RM (2000) Age-related changes in contractile responses of rabbit lower urinary tract to endothelin. J Urol 164:806–813
Webb ML, Liu ECK, Monshizadegan H, Chao CC, Lynch J, Fisher SM, Rose PM (1993) Expression of endothelin receptor subtypes in rabbit saphenous vein. Mol Pharmacol 44:959–965
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415
Yuyama H, Sanagi M, Koakutsu A, Mori M, Fujimori A, Harada H, Sudoh K, Miyata K (2003) Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ETA receptor antagonist. Eur J Pharmacol 478:61–71
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ukai, M., Yuyama, H., Noguchi, Y. et al. Participation of endogenous endothelin and ETA receptor in premicturition contractions in rats with bladder outlet obstruction. Naunyn-Schmied Arch Pharmacol 373, 197–203 (2006). https://doi.org/10.1007/s00210-006-0064-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-006-0064-3